PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $636,263 | -13.0% | 287,902 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $731,271 | +35.8% | 287,902 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $538,377 | -27.2% | 287,902 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $740,000 | +33.1% | 287,902 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $556,000 | -35.0% | 287,902 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $855,000 | -33.9% | 287,902 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $1,293,000 | -7.6% | 287,902 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $1,399,000 | -28.7% | 287,902 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $1,963,000 | -3.4% | 287,902 | 0.0% | 0.01% | -7.7% |
| Q1 2021 | $2,033,000 | +12.8% | 287,902 | 0.0% | 0.01% | +8.3% |
| Q4 2020 | $1,802,000 | +15.7% | 287,902 | 0.0% | 0.01% | +9.1% |
| Q3 2020 | $1,558,000 | +3.7% | 287,902 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,503,000 | +65.7% | 287,902 | 0.0% | 0.01% | +57.1% |
| Q1 2020 | $907,000 | -21.8% | 287,902 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $1,160,000 | -6.8% | 287,902 | 0.0% | 0.01% | -12.5% |
| Q3 2019 | $1,244,000 | +8.3% | 287,902 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $1,149,000 | -25.5% | 287,902 | 0.0% | 0.01% | -27.3% |
| Q1 2019 | $1,543,000 | +4.5% | 287,902 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $1,477,000 | -47.1% | 287,902 | 0.0% | 0.01% | -35.3% |
| Q3 2018 | $2,793,000 | -4.9% | 287,902 | 0.0% | 0.02% | -5.6% |
| Q2 2018 | $2,937,000 | -21.5% | 287,902 | 0.0% | 0.02% | -18.2% |
| Q1 2018 | $3,743,000 | -27.4% | 287,902 | 0.0% | 0.02% | -21.4% |
| Q4 2017 | $5,153,000 | -28.7% | 287,902 | 0.0% | 0.03% | -26.3% |
| Q3 2017 | $7,226,000 | -18.5% | 287,902 | -21.7% | 0.04% | -20.8% |
| Q2 2017 | $8,866,000 | +25.2% | 367,902 | 0.0% | 0.05% | +26.3% |
| Q1 2017 | $7,082,000 | +25.0% | 367,902 | 0.0% | 0.04% | +22.6% |
| Q4 2016 | $5,666,000 | +18.4% | 367,902 | 0.0% | 0.03% | +24.0% |
| Q3 2016 | $4,786,000 | -6.5% | 367,902 | 0.0% | 0.02% | -7.4% |
| Q2 2016 | $5,118,000 | -8.3% | 367,902 | 0.0% | 0.03% | -6.9% |
| Q1 2016 | $5,581,000 | -20.0% | 367,902 | 0.0% | 0.03% | -21.6% |
| Q4 2015 | $6,979,000 | -0.2% | 367,902 | 0.0% | 0.04% | +2.8% |
| Q3 2015 | $6,990,000 | -26.3% | 367,902 | 0.0% | 0.04% | -18.2% |
| Q2 2015 | $9,481,000 | – | 367,902 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|